New Access for Aortic Valve Replacement Achieves High Procedural Success in Italian Study of High Risk Patients PARIS – Medtronic, Inc. today issued a statement on results of clinical data presented ...

Patients with aortic stenosis who undergo transcatheter aortic valve replacement via the subclavian and femoral arteries have equivalent clinical outcomes at 30 days and 1 year, according to a new ...

Cardiac resynchronization therapy (CRT) is an established and guideline recommended therapy in patients with congestive heart failure with severely reduced systolic function and left bundle branch ...

Pisa, Italy - Two-year data from the Italian CoreValve (Medtronic) registry provide reassurance that the subclavian route is an acceptable alternative to the transfemoral route for transcatheter ...

October 12, 2011 (Lisbon, Portugal)— A recent presentation detailing outcomes from transcatheter aortic-valve implantation (TAVI) performed via the subclavian access route has exposed a battle going ...

Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ...

Approval is Expected to Expand Access to Care for Patients with Severe Aortic Stenosis MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the ...

The SAVES method is an effective and safe approach for ultrasound-guided infraclavicular axillary/subclavian vein cannulation. Cannulation is a procedure of inserting a flexible tube (catheter) into ...

CEREBROVASCULAR disease ranked third, after heart disease and cancer, as a cause of death in the United States in 1959. Almost 37,000 of these deaths occurred in persons between thirty-eight and sixty ...

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic ...